Fervent Synergies Ltd (FERVENTSYN) — shareholding pattern, promoter holding, financials and share price
About Fervent Synergies Ltd (FERVENTSYN)
Fervent Synergies Ltd operates in the Trading & Distributors industry, within the Services sector. It trades on the NSE as FERVENTSYN and on the BSE under scrip code 533896. Its ISIN is INE258M01011.
Incorporated in 2012, Fervent Synergies Ltd is in the business of food and finance
Fervent Synergies Ltd is engaged in the trading and distribution of pharmaceutical and chemical products, focusing on APIs, solvents, intermediates, and bulk drugs.
Originally incorporated as Fervent Pharma Synergies Ltd in 2009, the company underwent a name change in 2012 after mergers with Midas Pharmasec Ltd and Yew Investment Pvt Ltd.
Listed peers in Trading & Distributors: Variman Global Enterprises Ltd, Gautam Exim Ltd, Ganesha Ecoverse Ltd, Sharika Enterprises Ltd, Uma Exports Ltd, Chandni Machines Ltd.
Valuation & Returns
10 Jul 2026At ₹15.38 a share on 10 Jul 2026, Fervent Synergies Ltd (FERVENTSYN) was valued at a price-to-earnings ratio of 20.13x against an industry P/E of 21.24x and a price-to-book of 1.58x on a book value of ₹9.73 per share as of Mar 2025. Solomo computes return on equity of 7.85% and return on capital employed of 7.91% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 20.13x
- Industry P/E
- 21.24x
- P/B
- 1.58x
- EPS (TTM)
- ₹0.76
- Book value / share
- ₹9.73
- ROE
- 7.85%
- ROCE
- 7.91%
- ROA
- 7.83%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- 23.81%
- 52-week range
- ₹13.05 – ₹29.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Fervent Synergies Ltd (FERVENTSYN) reported revenue of ₹16.35 crore, net profit of ₹3.82 crore and earnings per share of ₹0.76. That compares with revenue of ₹32.46 crore and net profit of ₹2.95 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹5.2 crore and net profit ₹0.87 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 0.68 | 4.63 | 24.31 | 32.46 | 16.35 |
| Net profit (₹ cr) | -0.24 | 0.23 | -12.84 | 2.95 | 3.82 |
| EPS (₹) | -0.08 | 0.08 | -4.28 | 0.67 | 0.76 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 27.39% | 34.57% | 262.70% | 33.53% |
| Profit growth | 4.99% | 65.75% | - | 122.98% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.75% of Fervent Synergies Ltd (FERVENTSYN) (unchanged from the previous quarter). Market capitalisation was ₹77 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2011.
Largest disclosed public shareholders in Jun 2026: BLUE BERRY SECURITIES PVT LTD 4.95%, ILEX INVESTMENTS PRIVATE LIMITED 4.85%, HEMLATA SHANTILAL GALA 2.86%, PALMY SECURITIES PVT LTD 2.8%, DARVIN CONSULTANCY PVT LTD 2.6%, TASC CHEMICAL INDUSTRIES PVT LTD 2.4%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.75% | - | - | - | 25.25% |
| Mar 2026 | 74.75% | - | - | - | 25.25% |
| Dec 2025 | 74.75% | - | - | - | 25.25% |
| Sep 2025 | 74.75% | - | 0% | - | 25.25% |
| Jun 2025 | 74.75% | - | 0% | - | 25.25% |
| Mar 2025 | 71.71% | - | 0% | - | 28.29% |
| Dec 2024 | 73.33% | - | - | - | 26.67% |
| Sep 2024 | 73.33% | - | - | - | 26.67% |